Harvard gets $1.2M to develop oral antibiotics that kill drug-resistant infections

Harvard researchers receive $1.2 million from CARB-X to develop enhanced oral antibiotics for drug-resistant bacteria listed by CDC.

Related Keywords

Harvard University ,Massachusetts ,United States ,Boston ,Andrew Myers ,Erin Duffy ,Harvard University Andrewg Myers Research Group ,Boston University Led ,Resistant Threats ,Amory Houghton Professor ,Research Group ,Researchers ,Arb X ,Drug Resistant Bacteria ,Dc ,Antibiotic Resistant Threats ,Preclinical Development ,Chemical Optimization ,Mory Houghton Professor Of Chemistry ,